Who
Jane Elizabeth Keyser
Director
Company insider
Files Form 4 as: Director, Neuraxis.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 Jun 2024
- Last trade
- 13 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $164K26,073 at $6.28 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $164K26,073 at $6.28 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $100K21,598 at $4.63 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $100K21,598 at $4.63 | filing |
| 17 Jan 2025filed 10 Sep 2025 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | $37K13,157 at $2.85 | filing |
| 28 Jun 2024filed 2 Jul 2024 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —11,580 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.